Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
ARA-290
Clinical
Research chemical
Summary
Non-hematopoietic EPO-derived peptide studied for neuropathy and tissue-protective inflammation control.
Categories
Healing & Recovery, Cognitive & Nootropic
Mechanism
Selective innate repair receptor (IRR) engagement → anti-inflammatory and tissue-protective signaling without erythropoiesis.
Half-life
Short; frequent dosing in some study designs
Routes
Subcutaneous injection
Legal / access
Investigational; not a general approved neuropathy cure-all.
Key risks
- Generally studied as well tolerated
- Injection-site reactions
- Trial-specific events
Common claims
- Nerve pain relief
- Tissue repair without EPO blood effects
- Anti-inflammatory recovery
Select peptide B